Volumina Medical develops AdiPearl™, an injectable 3D scaffold designed for the reconstruction of soft tissue volumes through a minimally invasive procedure. This technology addresses the need for durable and natural-feeling tissue replacements in reconstructive and aesthetic surgery.
Funding
$27.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for soft tissue reconstruction often require invasive surgical procedures and may not provide durable, natural-feeling results. Existing solutions may lack the ability to be shaped and integrated seamlessly with the surrounding tissue.
Solution
Volumina Medical is developing AdiPearl™, an injectable 3D scaffold designed to reconstruct soft tissue volumes through a minimally invasive procedure. AdiPearl™ is a soft, structuring biomaterial that can be shaped upon injection, allowing for customized reconstruction. The technology aims to provide durable and natural-feeling tissue replacements in reconstructive and aesthetic surgery, addressing unmet needs in these markets. The platform of solutions is based on research performed at the Swiss Federal Institute of Technology Lausanne (EPFL).
Target Audience
The primary target audience includes surgeons in reconstructive and plastic surgery, as well as aesthetic medicine professionals seeking minimally invasive solutions for soft tissue volume reconstruction.
Features
- Injectable 3D scaffold for minimally invasive soft tissue reconstruction
- Soft and structuring material that can be shaped upon injection
- Designed for durable and natural-feeling tissue replacement
- Based on research from the Swiss Federal Institute of Technology Lausanne (EPFL)